APA (7th ed.) Citation

Arbogast, S., Dill, C., Ramahefasolo, C., Piemonte, F., Serreri, C., Lescure, A., . . . Ferreiro, A. (2014). G.P.209: N-acetylcysteine as an effective treatment in vivo and identification of biomarkers in SEPN1-related myopathy: A first preclinical trial. Neuromuscular Disorders, 24(9/10), 879. https://doi.org/10.1016/j.nmd.2014.06.285

Chicago Style (17th ed.) Citation

Arbogast, S., et al. "G.P.209: N-acetylcysteine as an Effective Treatment in Vivo and Identification of Biomarkers in SEPN1-related Myopathy: A First Preclinical Trial." Neuromuscular Disorders 24, no. 9/10 (2014): 879. https://doi.org/10.1016/j.nmd.2014.06.285.

MLA (9th ed.) Citation

Arbogast, S., et al. "G.P.209: N-acetylcysteine as an Effective Treatment in Vivo and Identification of Biomarkers in SEPN1-related Myopathy: A First Preclinical Trial." Neuromuscular Disorders, vol. 24, no. 9/10, 2014, p. 879, https://doi.org/10.1016/j.nmd.2014.06.285.